FDA Public Health Advisory: SSRI-Suicide link in adults Wed, 20 Jul 2005 The American Medical Association is attempting to trivialize the hazards of prescribing SSRIs to children, urging physicians not to allow the evidence to interfere with their prescribing habits. See: http://www.ama-assn.org/ama/pub/category/print/15186.html The AMA has done the public a disservice…
FDA: regulatory protections for children. Comments submitted by Vera Hassner Sharav, John H. Noble, Jr., Ph.D and Howard Fishman, MEd, MSW for AHRP August 6, 2001 To: Dr. Bernard Schwetz Acting Commissioner Food and Drug Administration Dockets Management Branch (HFA-305) Food and Drug Administration 5630 Fishers Lane, Room 1061 Rockville,…
AHRP InfoMail Return to Home Page Return to InfoMail Media Coverage List MediaCoverage News Stories on Human ResearchProtection andCommentary by Vera Hassner Sharav March 15a, 2002 Harm to Alzheimer ExperimentalPatients FYI ABC reports that Bob Helms, the self-described humanguinea pig, has written a book about his experience and observations about…
More detailed comments Children should not be tested for the Dryvax vaccine for the following reasons: 1) The original trials for the Dryvax vaccine already show that children respond similarly to adults when administered this substance. Since the effective dosage for adults has already been tested, it would be…
ALLIANCE FOR HUMAN RESEARCH PROTECTION* (AHRP) April 10, 2000 Gary Ellis, Ph.D, Director Michael A. Carome, M.D. Chief Compliance Oversight Branch Division of Human Subject Protections Office of Protection from Research Risks Rockville, MD 20892-7507 Re: High Risk Experiment With Children Who Have No Medical Diagnosis Dear Dr. Ellis &…
Date: Thu, 30 May 2002 14:14:47 -0400 From: Vera Subject: Bitter Medicine: Pills, Profit & the Public Health_ABC News ALLIANCE FOR HUMAN RESEARCH PROTECTION (AHRP) A Human Rights Organization www.researchprotection.org Contact: Vera Hassner Sharav FYI On May 17 The Wall Street Journal reported (in a front page article) that drug…
Lilly's aggressive marketing of Xigris does indeed epitomize the worst ofthis industry's mission.
The risks of the drugs far outweigh their benefits, said Vera Sharav, president of the Alliance for Human Research Protection, a New York-based consumer advocacy group.
Below the New York Times provides a summary of Crawford's selective disclosure and concealment of his financial holdings while he was
Commissioner, noting Crawford's ignoble tenure:
FDA's Dr. Steven Galson, like his predecessor who now occupies a position in the Commissioner's office, demonstrates disconnectedness from reality, much like Nero who fiddled while Rome burned…
"The drugs most commonly used to soothe agitation and aggression in people with Alzheimer’s disease are no more effective than placebos for most patients, and put them at risk of serious side effects, including confusion, sleepiness and Parkinson’s disease-like symptoms, researchers are reporting
today."
According to a investigative report issued by the Israeli Health Ministry, the doctors "conducted illegal and unethical testing on thousands of elderly patients for years.
